Centro Español de Investigación Farmacoepidemiológica-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2015

  1. Peptic ulcer bleeding risk. the role of helicobacter pylori infection in NSAID/low-dose aspirin users

    American Journal of Gastroenterology, Vol. 110, Núm. 5, pp. 684-689

  2. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants

    Clinical Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 906-912.e2

2014

  1. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high-or low-risk stigmata

    Scandinavian Journal of Gastroenterology, Vol. 49, Núm. 10, pp. 1181-1190

2013

  1. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: Comparison of event rates in routine clinical practice and a clinical trial

    Scandinavian Journal of Gastroenterology, Vol. 48, Núm. 3, pp. 285-294

2011

  1. The changing face of hospitalisation due to gastrointestinal bleeding and perforation

    Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 585-591

2007

  1. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

    American Journal of Gastroenterology, Vol. 102, Núm. 3, pp. 507-515